Vigilant Biosciences, Inc.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Vigilant Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2019).
SEC Form D · Nov 2019
The industry group it chose in its notices: Other Health Care.
SEC Form D · Nov 2019
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Vigilant Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Robert Hamilton | Executive officer | Nov 2019 |
| William Brodie | Executive officer | Nov 2019 |
| Stuart Heap | Executive officer | Jun 2018 |
| Matthew H.J. Kim | Executive officer | Feb 2016 |
| Robert T. Hamilton | Executive officer | Feb 2016 |
| Matthew H. J. Kim | Executive officer | Mar 2015 |
| Linda Niessen | Director | Nov 2019 |
| Timothy Barabe | Director | Nov 2019 |
| William Brodie | Director | Nov 2019 |
| Eric Stone | Director | Jun 2018 |
| Stuart Heap | Director | Jun 2018 |
| Eric M. Stone | Director | Feb 2016 |
| Linda C. Niessen | Director | Feb 2016 |
| Matthew H.J. Kim | Director | Feb 2016 |
| Timothy C. Barabe | Director | Feb 2016 |
| Eric H. J. Stone | Director | Mar 2015 |
| Matthew H. J. Kim | Director | Mar 2015 |
| Timothy H. J. Barabe | Director | Mar 2015 |
| Jeffrey H. J. Goodman | Director | Mar 2014 |
| Jonathan T. Lord | Director | Mar 2014 |